Live from the NIH registry
Studies recruiting near McAllen right now
Top 25 of 136 recruiting studies, sorted by proximity — each links to its official registry page
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
DHR Health Advance Care Center — Edinburg, Texas (7.4 mi)
· Sponsor: Guardant Health, Inc.
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
Gamma Medical Research — McAllen, Texas (1.8 mi)
· Sponsor: R1 Therapeutics
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
ADARx Clinical Site — McAllen, Texas (1.8 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
HCA Research Institute — McAllen, Texas (1.8 mi)
· Sponsor: Novo Nordisk A/S
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
DHR Health Institute for Research — McAllen, Texas (1.8 mi)
· Sponsor: Duke University
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Nova Oncology — McAllen, Texas (1.8 mi)
· Sponsor: Eli Lilly and Company
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 7062 — Edinburg, Texas (7.4 mi)
· Sponsor: Galderma R&D
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 143 participants sought
DHR Health Gastroenterology - Edinburg — Edinburg, Texas (7.4 mi)
· Sponsor: Eli Lilly and Company
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Biopharma Informatic-McAllen — McAllen, Texas (1.8 mi)
· Sponsor: Amgen
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Urothelial Cancer, Advanced/Metastatic Urothelial Cancer
Phase 1, Phase 2
Interventional 132 participants sought
Texas Oncology - Central/South Texas — McAllen, Texas (1.8 mi)
· Sponsor: Pfizer
EDX110 Randomized Control Trial for Treatment of DFUs
Wound Heal, Diabetic Foot Ulcer
N/A
Interventional 298 participants sought
Futuro Clinical Trials — McAllen, Texas (1.8 mi)
· Sponsor: ConvaTec Inc.
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Valley Retina Institute — McAllen, Texas (1.8 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Myositis
Phase 3
Interventional 318 participants sought
Pulmonary and Sleep Center of the Valley — Weslaco, Texas (16.5 mi)
· Sponsor: Pfizer
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer, Metastatic Breast Cancer
Phase 3
Interventional 404 participants sought
Texas Oncology McAllen — McAllen, Texas (1.8 mi)
· Sponsor: BriaCell Therapeutics Corporation
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Texas Oncology -Central South — McAllen, Texas (1.8 mi)
· Sponsor: Pfizer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
STCC at DHR Health Institute for Research and Development — Edinburg, Texas (7.4 mi)
· Sponsor: NRG Oncology
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Osteoarthritis, Overweight or Obesity
Phase 3
Interventional 900 participants sought
Texas Valley Clinical Research — Weslaco, Texas (16.5 mi)
· Sponsor: Eli Lilly and Company
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Multiple Sclerosis
Phase 4
Interventional 100 participants sought
DHR Health MS Center — McAllen, Texas (1.8 mi)
· Sponsor: Genentech, Inc.
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Non Small Cell Lung Cancer
Phase 3
Interventional 630 participants sought
Texas Oncology - McAllen - 1132 — McAllen, Texas (1.8 mi)
· Sponsor: OncoC4, Inc.
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Ventricular Ejection Fraction, LVF
N/A
Observational 2,000 participants sought
South Heart Clinic — Weslaco, Texas (16.5 mi)
· Sponsor: Peerbridge Health, Inc
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Biopharma Informatic, LLC — McAllen, Texas (1.8 mi)
· Sponsor: Novo Nordisk A/S
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Obesity or Overweight
Phase 3
Interventional 300 participants sought
South Texas Research Institute — Edinburg, Texas (7.4 mi)
· Sponsor: Amgen
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers
Diabetic Foot Ulcer
N/A
Interventional 450 participants sought
Futuro Clinical Trials, LLC — McAllen, Texas (1.8 mi)
· Sponsor: Piomic Medical
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Venous Thromboembolism (VTE)
Phase 3
Interventional 2,000 participants sought
Futuro Clinical Trials — McAllen, Texas (1.8 mi)
· Sponsor: Regeneron Pharmaceuticals
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Pneumococcal Immunization, Healthy Volunteers
Phase 3
Interventional 2,195 participants sought
PAS Research - Children's Care Clinic- Site Number : 8400035 — Edinburg, Texas (7.4 mi)
· Sponsor: Sanofi